Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease

NCT03147014 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2018-12-04

No results posted yet for this study

Summary

Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease

Conditions

Interventions

BIOLOGICAL

Maternal hyperoxygenation

approximately 10-15 minutes of maternal hyperoxygenation

Sponsors & Collaborators

  • Beijing Anzhen Hospital

    lead OTHER

Principal Investigators

  • Yihua He, MD · Beijing Anzhen Hospital

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-01-01
Primary Completion
2021-12-31
Completion
2022-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03147014 on ClinicalTrials.gov